V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005678 | 280003582 | 1.53 | 95 | Palliative (P) | 2017-03-13 | 2017-03-13 | Oxaliplatin + Modified de Gramont | 02 | N | 280029511 | CARBOPLATIN + PEMETREXED |
| 280005679 | 280003582 | 1.62 | 69.7 | Adjuvant (A) | 2013-03-22 | 2013-03-22 | EW EuroEwing 99 : VIDE | 02 | N | 280029511 | MITOMYCIN |
| 280005680 | 280003582 | 1.93 | 75 | Curative (C) | 2017-12-16 | 2017-12-24 | DOCETAXEL + GEMCITABINE | 2 | N | 280029511 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280005681 | 280003583 | 1.86 | 93.6 | Palliative (P) | null | 2015-03-28 | Carboplatin + Pemetrexed | null | null | 280029517 | CETUXIMAB + CISPLATIN + FU |
| 280005682 | 280003584 | 1.7 | 69.7 | Palliative (P) | 2017-07-24 | 2017-08-07 | Cetuximab +Cisplatin + FU (Cycle 1) | N | Y | 280029519 | LIPOSOMAL DOXORUBICIN |
| 280005683 | 280007916 | 1.7 | 91 | Curative (C) | 2014-05-23 | 2014-05-25 | DABRAFENIB | 02 | N | 280029520 | CISPLATIN + FLUOROURACIL + RT |
| 280005684 | 280007916 | 1.74 | 77 | Adjuvant (A) | 2018-06-13 | 2018-07-01 | Carboplatin + Pemetrexed | N | N | 280029520 | CISPLATIN + VINORELBINE |
| 280005685 | 280011085 | 1.8 | 71.1 | Palliative (P) | 2018-03-10 | 2018-03-10 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280029522 | PACLITAXEL |
| 280005686 | 280011085 | 1.58 | 70 | Palliative (P) | 2016-07-22 | 2016-08-17 | Temozolomide 150mg/m2 | Y | Y | 280029522 | GEMCARBO |
| 280005687 | 280003585 | 1.56 | 77 | Curative (C) | 2015-05-18 | 2015-05-23 | DABRAFENIB | N | N | 280029524 | EURO-EWING |
| 280005688 | 280007917 | null | 95.6 | Disease modification (D) | 2017-01-23 | 2017-02-06 | GEMCARBO | N | null | 280029525 | BCG |
| 280005689 | 280010033 | 1.67 | 65.2 | Neo-adjuvant (N) | null | 2018-01-22 | CARBOPLATIN + VINORELBINE | N | N | 280029529 | TCF |
| 280005690 | 280003586 | 1.58 | 70 | null | 2016-07-01 | 2016-07-03 | Gemcitabine weekly | Y | null | 280029531 | ETOPOSIDE |
| 280005691 | 280003586 | 1.65 | 82.8 | Palliative (P) | 2016-11-11 | 2016-12-10 | Carboplatin + Pemetrexed | N | N | 280029531 | CARBO + FLUOROURACIL |
| 280005692 | 280003587 | null | null | null | 2016-05-20 | 2016-06-08 | MELPHALAN | N | N | 280029535 | VINCRISTINE |
| 280005693 | 280007919 | null | null | Palliative (P) | 2013-02-23 | 2013-03-08 | Carbo F | N | N | 280029539 | PACLITAXEL |
| 280005694 | 280003588 | 1.5 | 76 | Adjuvant (A) | null | 2014-08-19 | BCG Intravesical | null | null | 280029540 | EURO-EWING |
| 280005695 | 280003588 | 1.83 | 79.6 | Palliative (P) | 2016-03-30 | 2016-04-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280029540 | CARBO + FLUOROURACIL |
| 280005696 | 280003589 | 1.8 | 62 | Curative (C) | 2017-11-13 | 2017-11-24 | DABRAFENIB + TRAMETINIB | N | N | 280029542 | COMPARE TRIAL |
| 280005697 | 280007921 | 1.8 | 91.6 | Curative (C) | 2016-06-04 | 2016-06-21 | Capecitabine + Oxaliplatin 21day | 02 | N | 280029543 | VIDE |
| 280005698 | 280003590 | 1.55 | null | Palliative (P) | 2017-05-23 | 2017-06-14 | CYCLOPHOSPHAMIDE | N | N | 280029546 | GEMCARBO |
| 280005699 | 280003591 | 1.74 | 0 | null | 2015-01-12 | 2015-01-25 | Ipilimumab | N | N | 280029548 | EURO-EWING |
| 280005700 | 280003591 | null | 102 | Palliative (P) | 2015-01-07 | 2015-01-07 | ECX | N | N | 280029548 | CISPLATIN + DOCETAXEL |
| 280005701 | 280003592 | 1.63 | 100.2 | Palliative (P) | 2013-05-31 | 2013-06-19 | Ipilimumab | N | N | 280029552 | CETUXIMAB + CISPLATIN + FU |
| 280005702 | 280007923 | 1.73 | null | Palliative (P) | 2015-03-14 | 2015-04-05 | OCTREOTIDE | null | N | 280029554 | DOXORUBICIN + OLARATUMAB |
| 280005703 | 280007923 | 1.73 | 81 | Palliative (P) | 2017-03-04 | 2017-03-13 | PEMBROLIZUMAB | 2 | N | 280029554 | CETUXIMAB + CISPLATIN + FU |
| 280005704 | 280007923 | null | 107.35 | null | null | 2017-11-13 | EW EuroEwing 99 : VActC | null | null | 280029554 | TRABECTEDIN |
| 280005705 | 280003593 | 0 | 51.6 | Adjuvant (A) | 2017-06-10 | 2017-06-11 | DE-ESCALATE TRIAL | N | N | 280029559 | CISPLATIN + VINORELBINE |
| 280005706 | 280003593 | 1.63 | null | Palliative (P) | null | 2013-12-19 | CYCLOPHOSPHAMIDE | null | null | 280029559 | PACLITAXEL |
| 280005707 | 280003593 | 1.78 | 87 | Palliative (P) | null | 2015-08-20 | GEMCARBO | N | N | 280029559 | IRINOTECAN + MDG |
| 280005708 | 280011087 | 1.58 | null | Adjuvant (A) | 2017-12-27 | 2018-01-03 | Capecitabine + Oxaliplatin 21day | N | N | 280029564 | FEC |
| 280005709 | 280011087 | 1.62 | 88 | Palliative (P) | 2015-08-20 | 2015-09-03 | CARBOPLATIN + VINORELBINE | N | N | 280029564 | CVP R |
| 280005710 | 280003594 | 1.78 | 58.9 | Palliative (P) | 2013-03-06 | 2013-03-06 | Trabectedin | 2 | N | 280029568 | TRABECTEDIN |
| 280005711 | 280003594 | 1.7 | null | Neo-adjuvant (N) | 2013-12-13 | 2013-12-20 | DOCETAXEL + GEMCITABINE | 02 | N | 280029568 | CARBO + FLUOROURACIL |
| 280005712 | 280003595 | 1.75 | 124 | Curative (C) | 2017-03-11 | 2017-11-21 | DA 3 + 10 | N | N | 280029574 | DE-ESCALATE TRIAL |
| 280005713 | 280003595 | 1.72 | 70 | Palliative (P) | 2015-12-17 | 2016-01-12 | GemCarbo Days 1+8 | 02 | N | 280029574 | CISPLATIN + FLUOROURACIL + RT |
| 280005714 | 280003596 | 1.71 | 70 | Palliative (P) | 2016-07-08 | 2016-07-24 | VIDE | 02 | Y | 280029577 | DOXORUBICIN + OLARATUMAB |
| 280005715 | 280003597 | 1.69 | 87.3 | Curative (C) | 2017-02-05 | 2017-02-05 | Oxaliplatin + Modified de Gramont | N | N | 280029578 | CHOP R |
| 280005716 | 280003597 | 1.7 | 81.8 | Curative (C) | 2015-11-22 | 2015-11-29 | ARISTOTLE TRIAL | 02 | N | 280029578 | RMS 2005 TRIAL |
| 280005717 | 280003597 | 1.82 | 118 | Neo-adjuvant (N) | 2013-06-18 | 2013-06-27 | VIDE | N | N | 280029578 | EURO-EWING |
| 280005718 | 280003597 | 1.84 | 75 | Curative (C) | 2017-11-15 | 2017-11-15 | Trabectedin | 02 | N | 280029578 | IVA |
| 280005719 | 280003598 | 1.88 | 82.25 | Curative (C) | 2015-09-10 | 2015-09-15 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280029584 | VIDE |
| 280005720 | 280003599 | 1.73 | 101.3 | Curative (C) | 2015-06-12 | 2015-06-13 | Liposomal Doxorubicin (Caelyx) | 99 | null | 280029586 | GDP |
| 280005721 | 280003599 | 1.74 | null | Neo-adjuvant (N) | null | 2014-10-15 | Carbo F | null | null | 280029586 | EURO-EWING |
| 280005722 | 280003600 | 1.61 | 54.4 | Palliative (P) | 2014-05-29 | 2014-05-29 | CompARE Trial | N | N | 280029590 | PERTUZUMAB + TRASTUZUMAB |
| 280005723 | 280007929 | null | 166.8 | Neo-adjuvant (N) | 2013-10-19 | 2013-10-22 | DE-ESCALATE TRIAL | N | N | 280029591 | IVA |
| 280005724 | 280010037 | null | null | Palliative (P) | null | 2013-08-25 | Capecitabine + Streptozocin | N | N | 280029592 | CARBOPLATIN + PEMETREXED |
| 280005725 | 280010037 | 1.78 | 64 | Palliative (P) | 2014-02-04 | 2014-02-18 | Capecitabine | N | N | 280029592 | PACLITAXEL |
| 280005726 | 280003601 | 1.79 | 118 | Curative (C) | 2015-11-02 | 2015-11-06 | ECX | 02 | Y | 280029594 | RMS 2005 TRIAL |
| 280005727 | 280007930 | null | null | null | 2015-07-18 | 2015-08-02 | Capecitabine | N | N | 280029597 | MELPHALAN |